Regular Exercise Modifies Histopathological Outcomes of Pharmacological Treatment in Experimental Autoimmune Encephalomyelitis

Regular Exercise Modifies Histopathological Outcomes of Pharmacological Treatment in Experimental Autoimmune Encephalomyelitis

Background: Although it has been suggested that healthier lifestyle may optimize effects of the immunomodulation drugs for treating multiple sclerosis (MS), the knowledge regarding this kind of interactions is limited.Objective: The aim of the present study was to investigate the effects of treadmil...

Full description

Bibliographic Details
Main Authors:	Danielle Bernardes, Alexandre Leite Rodrigues de Oliveira
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-11-01
Series:	Frontiers in Neurology
Subjects:	experimental autoimmune encephalomyelitis (EAE) treadmill exercise disease modifying therapies (DMTs) glatiramer acetate (GA) dimethyl fumarate (DMF)
Online Access:	https://www.frontiersin.org/article/10.3389/fneur.2018.00950/full

Similar Items

Novel approaches in the treatment of multiple sclerosis
by: Stepanović-Petrović Radica, et al.
Published: (2015-01-01)

Molecular Effects of FDA-Approved Multiple Sclerosis Drugs on Glial Cells and Neurons of the Central Nervous System
by: Kim M. A. De Kleijn, et al.
Published: (2020-06-01)

Glatiramer Acetate, Dimethyl Fumarate and Monomethyl Fumarate Up-Regulate the Expression of CCR10 on the Surface of Natural Killer Cells and Enhance their Chemotaxis and Cytotoxicity. Implications for Cancer Immunotherapy
by: Azzam Maghazachi, et al.
Published: (2016-10-01)

Natalizumab promotes activation and pro-inflammatory differentiation of peripheral B cells in multiple sclerosis patients
by: Jan W. Traub, et al.
Published: (2019-11-01)

Comparison of first-line therapies for relapsing-remitting multiple sclerosis
by: Yennam, Amulya
Published: (2021)

Synthetic Cationic Autoantigen Mimics Glatiramer Acetate Persistence at the Site of Injection and Is Efficacious Against Experimental Autoimmune Encephalomyelitis
by: Jimmy Y. Song, et al.
Published: (2021-01-01)

Hormones in experimental autoimmune encephalomyelitis (EAE) animal models
by: Ghareghani Majid, et al.
Published: (2021-05-01)

Theta burst stimulation influence the expression of BDNF in the spinal cord on the experimental autoimmune encephalomyelitis
by: Ivana Stevanovic, et al.
Published: (2019-06-01)

Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms
by: M. Moransard, et al.
Published: (2017-10-01)

Differential Effects of MS Therapeutics on B Cells—Implications for Their Use and Failure in AQP4-Positive NMOSD Patients
by: Jan Traub, et al.
Published: (2020-07-01)

Galangin ameliorates experimental autoimmune encephalomyelitis in mice via modulation of cellular immunity
by: Kok-Tong Tan, et al.
Published: (2021-03-01)

The immunomodulator glatiramer acetate influences spinal motoneuron plasticity during the course of multiple sclerosis in an animal model
by: K.B. Marques, et al.
Published: (2009-02-01)

Clozapine Regulates Microglia and Is Effective in Chronic Experimental Autoimmune Encephalomyelitis
by: Ulaş Ceylan, et al.
Published: (2021-05-01)

Modulation of fibronectin expression in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis
by: De-Carvalho M.C.A., et al.
Published: (1999-01-01)

In Vivo Induction of Regulatory T Cells Via CTLA‐4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse
by: Gil‐Ran Kim, et al.
Published: (2021-07-01)

Sildenafil Alleviates Murine Experimental Autoimmune Encephalomyelitis by Triggering Autophagy in the Spinal Cord
by: Eduardo Duarte-Silva, et al.
Published: (2021-05-01)

Estudio comparativo de melatonina contra los tratamientos inmunomoduladores (interferón beta y acetato de glatirámero) en un modelo murino de esclerosis múltiple
by: E.J. Ramos González, et al.
Published: (2021-05-01)

Induction of Regulatory Properties in the Intestinal Immune System by Dimethyl Fumarate in Lewis Rat Experimental Autoimmune Neuritis
by: Kalliopi Pitarokoili, et al.
Published: (2019-09-01)

Up-Regulation of Tmevpg1 and Rmrp LncRNA Levels in Splenocytes and Brain of Mouse with Experimental Autoimmune Encephalomyelitis
by: E Farahani, et al.
Published: (2019-08-01)

Immunomodulation Eliminates Inflammation in the Hippocampus in Experimental Autoimmune Encephalomyelitis, but Does Not Ameliorate Anxiety-Like Behavior
by: Pece Kocovski, et al.
Published: (2021-06-01)

The Crotoxin:SBA-15 Complex Down-Regulates the Incidence and Intensity of Experimental Autoimmune Encephalomyelitis Through Peripheral and Central Actions
by: Morena Brazil Sant'Anna, et al.
Published: (2020-10-01)

Letter to the Editor Regarding: A Comprehensive Review on Copemyl®
by: Giancarlo Comi, et al.
Published: (2018-11-01)

Effect of dimethyl fumarate on heme oxygenase-1 expression in experimental allergic encephalomyelitis in rats
by: Kaja Kasarełło, et al.
Published: (2017-12-01)

Dimethyl Fumarate, an Approved Multiple Sclerosis Treatment, Reduces Brain Oxidative Stress in SIV-Infected Rhesus Macaques: Potential Therapeutic Repurposing for HIV Neuroprotection
by: Yoelvis Garcia-Mesa, et al.
Published: (2021-03-01)

Pertussis vaccine-induced experimental autoimmune encephalomyelitis in mice
by: Stojković Aleksandra, et al.
Published: (2014-03-01)

K+ channel alterations in the progression of experimental autoimmune encephalomyelitis
by: Peter I. Jukkola, et al.
Published: (2012-08-01)

Nigella sativa as an anti-inflammatory and promising remyelinating agent in the cortex and hippocampus of experimental autoimmune encephalomyelitis-induced rats
by: Heba M. Fahmy, et al.
Published: (2014-10-01)

Use of glatiramer acetate between 2010–2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patients
by: Chiara Zecca, et al.
Published: (2019-07-01)

The role of the lung in shaping CNS autoimmunity
by: Hosang, Leon
Published: (2019)

Gene Expression in Spontaneous Experimental Autoimmune Encephalomyelitis Is Linked to Human Multiple Sclerosis Risk Genes
by: Hans Faber, et al.
Published: (2020-09-01)

Pharmacokinetics of the Yougui pill in experimental autoimmune encephalomyelitis model rats and its pharmacological activity in vitro
by: Liu H, et al.
Published: (2019-07-01)

Co-treatments to Boost IDO Activity and Inhibit Production of Downstream Catabolites Induce Durable Suppression of Experimental Autoimmune Encephalomyelitis
by: Henrique Lemos, et al.
Published: (2020-06-01)

The Immunomodulatory and Neuroprotective Effects of Mesenchymal Stem Cells (MSCs) in Experimental Autoimmune Encephalomyelitis (EAE): A Model of Multiple Sclerosis (MS)
by: Mohamed H. Abumaree, et al.
Published: (2012-07-01)

Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience
by: Aurora Zanghì, et al.
Published: (2020-02-01)

IL-9-triggered lncRNA Gm13568 regulates Notch1 in astrocytes through interaction with CBP/P300: contribute to the pathogenesis of experimental autoimmune encephalomyelitis
by: Xiaomei Liu, et al.
Published: (2021-05-01)

Autoimmune T cell - B cell interaction in experimental autoimmune encephalomyelitis
by: Flach, Anne-Christine
Published: (2015)

Immune Thymic Profile of the MOG-Induced Experimental Autoimmune Encephalomyelitis Mouse Model
by: Sofia P. das Neves, et al.
Published: (2018-10-01)

Gliotoxin Aggravates Experimental Autoimmune Encephalomyelitis by Triggering Neuroinflammation
by: Thais Fernanda de Campos Fraga-Silva, et al.
Published: (2019-07-01)

Hydroxycarboxylic Acid Receptor 2, a Pleiotropically Linked Receptor for the Multiple Sclerosis Drug, Monomethyl Fumarate. Possible Implications for the Inflammatory Response
by: Benedetta Parodi, et al.
Published: (2021-05-01)

Oleanolic Acid Acetate Alleviates Symptoms of Experimental Autoimmune Encephalomyelitis in Mice by Regulating Toll-Like Receptor 2 Signaling
by: Minju Kim, et al.
Published: (2020-09-01)

Cannot write session to /tmp/vufind_sessions/sess_259j20oarq1hl7idbs7blvrcvf